Thrombocytosis, pregnancy, and regression toward mean

Blood

Volumn 110, Issue 2, 2007, Pages 472-473

  Spivak, Jerry L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2;

CHRONIC MYELOID LEUKEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; INTRAUTERINE GROWTH RETARDATION; LEUKOCYTE COUNT; NEUTROPHIL; NOTE; PHLEBOTOMY; PLASMA VOLUME; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOSIS; THROMBOPHILIA;

EID: 34547130084     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-04-086330     Document Type: Note

References (7)

1. Griesshammer M, Struve S, Harrison CM. Essential thrombocythemia/ polycythemia vera and pregnancy: the need for an observational study in Europe. Semin Thromb Hemost. 2006;32:422-429.
2. Moliterno AR, Williams DM, Rogers O, Spivak JL. Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expression. Blood. 2006;108:3913-3915.
3. Campbell PJ, Scott LM, Buck G, et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study. Lancet. 2005;366:1945-1953.
4. Johansson PL, Safai-Kutti S, Kutti J. An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia. Br J Haematol. 2005;129:701-705.
5. Lindqvist PG, Merlo J. The natural course of women with recurrent fetal loss. J Thromb Haemost. 2006;4:896-897.
6. Spivak JL. Polycythemia vera: myths, mechanisms, and management. Blood. 2002;100:4272-4290.
7. Harrison CN, Campbell PJ, Buck G, et al. Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. NEngl J Med. 2005;353:33-45.